Literature DB >> 22728325

Neuroendocrine influences on cancer progression.

Guillermo N Armaiz-Pena1, Steve W Cole, Susan K Lutgendorf, Anil K Sood.   

Abstract

During the past decade, new studies have continued to shed light on the role of neuroendocrine regulation of downstream physiological and biological pathways relevant to cancer growth and progression. More specifically, our knowledge of the effects of the sympathetic nervous system (SNS) on cancer biology has been greatly expanded by new data demonstrating how the cellular immune response, inflammatory processes, tumor-associated angiogenesis, and tumor cell invasion and survival converge to promote tumor growth. This review will summarize these studies, while synthesizing clinical, cellular and molecular research that has continued to unearth the biological events mediating the interplay between SNS-related processes and cancer progression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22728325      PMCID: PMC3467346          DOI: 10.1016/j.bbi.2012.06.005

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  67 in total

1.  Neuroendocrine regulation of immunity.

Authors:  Jeanette I Webster; Leonardo Tonelli; Esther M Sternberg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  Stress-induced immune dysfunction: implications for health.

Authors:  Ronald Glaser; Janice K Kiecolt-Glaser
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

3.  The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.

Authors:  S Basu; J A Nagy; S Pal; E Vasile; I A Eckelhoefer; V S Bliss; E J Manseau; P S Dasgupta; H F Dvorak; D Mukhopadhyay
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

Review 4.  Molecular pathways: beta-adrenergic signaling in cancer.

Authors:  Steven W Cole; Anil K Sood
Journal:  Clin Cancer Res       Date:  2011-12-20       Impact factor: 12.531

5.  Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells.

Authors:  T Nakane; T Szentendrei; L Stern; M Virmani; J Seely; G Kunos
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

6.  Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition.

Authors:  Lei Cao; Xianglan Liu; En-Ju D Lin; Chuansong Wang; Eugene Y Choi; Veronique Riban; Benjamin Lin; Matthew J During
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

7.  Norepinephrine in the rat ovary: ontogeny and de novo synthesis.

Authors:  N Ben-Jonathan; L A Arbogast; T A Rhoades; J M Bahr
Journal:  Endocrinology       Date:  1984-10       Impact factor: 4.736

8.  Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.

Authors:  Susan K Lutgendorf; Steven Cole; Erin Costanzo; Sarah Bradley; Jeremy Coffin; Sarvenaz Jabbari; Kaitlin Rainwater; Justine M Ritchie; Maria Yang; Anil K Sood
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

9.  Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.

Authors:  Susan K Lutgendorf; Donald M Lamkin; Nicholas B Jennings; Jesusa M G Arevalo; Frank Penedo; Koen DeGeest; Robert R Langley; Joseph A Lucci; Steve W Cole; David M Lubaroff; Anil K Sood
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

10.  A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1.

Authors:  Makoto R Hara; Jeffrey J Kovacs; Erin J Whalen; Sudarshan Rajagopal; Ryan T Strachan; Wayne Grant; Aaron J Towers; Barbara Williams; Christopher M Lam; Kunhong Xiao; Sudha K Shenoy; Simon G Gregory; Seungkirl Ahn; Derek R Duckett; Robert J Lefkowitz
Journal:  Nature       Date:  2011-08-21       Impact factor: 49.962

View more
  47 in total

Review 1.  Sympathetic nervous system regulation of the tumour microenvironment.

Authors:  Steven W Cole; Archana S Nagaraja; Susan K Lutgendorf; Paige A Green; Anil K Sood
Journal:  Nat Rev Cancer       Date:  2015-09       Impact factor: 60.716

Review 2.  The impact of psychosocial stress and stress management on immune responses in patients with cancer.

Authors:  Michael H Antoni; Firdaus S Dhabhar
Journal:  Cancer       Date:  2019-02-15       Impact factor: 6.860

Review 3.  Psychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovations.

Authors:  Paige Green McDonald; Mary O'Connell; Susan K Lutgendorf
Journal:  Brain Behav Immun       Date:  2013-01-16       Impact factor: 7.217

Review 4.  Review of yoga therapy during cancer treatment.

Authors:  Suzanne C Danhauer; Elizabeth L Addington; Stephanie J Sohl; Alejandro Chaoul; Lorenzo Cohen
Journal:  Support Care Cancer       Date:  2017-01-07       Impact factor: 3.603

5.  Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor.

Authors:  Jeffrey S Stehouwer; Matthew S Birnbaum; Ronald J Voll; Michael J Owens; Susan J Plott; Chase H Bourke; Michael A Wassef; Clinton D Kilts; Mark M Goodman
Journal:  Bioorg Med Chem       Date:  2015-06-19       Impact factor: 3.641

6.  Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers.

Authors:  H Lavon; P Matzner; A Benbenishty; L Sorski; E Rossene; R Haldar; E Elbaz; J P Cata; V Gottumukkala; S Ben-Eliyahu
Journal:  Br J Anaesth       Date:  2017-11-23       Impact factor: 9.166

7.  Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.

Authors:  Susan K Lutgendorf; Premal H Thaker; Jesusa M Arevalo; Michael J Goodheart; George M Slavich; Anil K Sood; Steve W Cole
Journal:  Cancer       Date:  2017-11-07       Impact factor: 6.860

8.  PGE2 suppresses NK activity in vivo directly and through adrenal hormones: effects that cannot be reflected by ex vivo assessment of NK cytotoxicity.

Authors:  G Meron; Y Tishler; L Shaashua; E Rosenne; B Levi; R Melamed; N Gotlieb; P Matzner; L Sorski; S Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2012-11-12       Impact factor: 7.217

Review 9.  Nervous system regulation of the cancer genome.

Authors:  Steven W Cole
Journal:  Brain Behav Immun       Date:  2012-12-01       Impact factor: 7.217

10.  Cancer's got nerve: Schwann cells drive perineural invasion.

Authors:  Salma H Azam; Chad V Pecot
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.